Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210
Zhiyong Yang, Ning Zhao, Jing Cui, et al.
Cellular Oncology (2019) Vol. 43, Iss. 1, pp. 123-136
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

Exosomes: key players in cancer and potential therapeutic strategy
Jie Dai, Yangzhou Su, Suye Zhong, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 899
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Sepideh Mirzaei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 362
Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
Heming Zhou, Jigang Zhang, Xue Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 325
Cancer nanotechnology: current status and perspectives
Jessica A. Kemp, Young Jik Kwon
Nano Convergence (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 178
Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
Yang Qiu-rong, Jing Xu, Jianmei Gu, et al.
Advanced Science (2022) Vol. 9, Iss. 34
Open Access | Times Cited: 81
Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer
Jianyou Gu, Wenjie Huang, Xianxing Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 75
Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
Minru Liao, Dahong Yao, Lifeng Wu, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 953-1008
Open Access | Times Cited: 48
Current Perspectives of Protein in Bone Tissue Engineering: Bone Structure, Ideal Scaffolds, Fabrication Techniques, Applications, Scopes, and Future Advances
Muhammad Umar Aslam Khan, Muhammad Azhar Aslam, Mohd Faizal Abdullah, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 8, pp. 5082-5106
Closed Access | Times Cited: 21
Exploring extracellular RNA as drivers of chemotherapy resistance in cancer
Yumna Khan, Md Sadique Hussain, Prasanna Srinivasan Ramalingam, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 2
The key roles of cancer stem cell-derived extracellular vesicles
Chaoyue Su, Jianye Zhang, Yosef Yarden, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 95
Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance
Patrick Santos, Fausto Almeida
Cells (2020) Vol. 9, Iss. 6, pp. 1450-1450
Open Access | Times Cited: 91
DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications
Kah Keng Wong
Cellular Oncology (2020) Vol. 43, Iss. 5, pp. 779-792
Closed Access | Times Cited: 80
Pancreatic stellate cells derived exosomal miR-5703 promotes pancreatic cancer by downregulating CMTM4 and activating PI3K/Akt pathway
Mingzhe Li, Huahu Guo, Qi Wang, et al.
Cancer Letters (2020) Vol. 490, pp. 20-30
Closed Access | Times Cited: 79
Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
Tomas Koltai, Stephan J. Reshkin, Tiago M. A. Carvalho, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2486-2486
Open Access | Times Cited: 66
MiRNA-mediated EMT and CSCs in cancer chemoresistance
Bing Dong, Shiyu Li, Shuangli Zhu, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 65
A Review: Surface Engineering of Lipid‐Based Drug Delivery Systems
Dhaval Patel, Jyoti Solanki, Mafatlal M. Kher, et al.
Small (2024) Vol. 20, Iss. 43
Open Access | Times Cited: 15
Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers
Yuan Li, Silei Sui, Ajay Goel
Seminars in Cancer Biology (2024) Vol. 99, pp. 5-23
Closed Access | Times Cited: 12
Extracellular Vesicular miRNA in Pancreatic Cancer: From Lab to Therapy
Prashant Tiwari, Poojhaa Shanmugam, Vamika Karn, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2179-2179
Open Access | Times Cited: 8
Exosome crosstalk between cancer stem cells and tumor microenvironment: cancer progression and therapeutic strategies
Qi Li, Guangpeng He, Yifan Yu, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
FXYD5 regulates gastric cancer cell metastasis and drug resistance by EMT modulation
Yuning Mao, Yaohua Hu, Han Meng, et al.
Cancer Gene Therapy (2025)
Closed Access | Times Cited: 1
Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2
Yonghao Zhan, Zhenzhen Zhou, Zhaowei Zhu, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
The Role of Exosomal microRNA in Cancer Drug Resistance
Qiao-ru Guo, Hui Wang, Ying-da Yan, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 55
Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications
Moritz Reese, Sameer A. Dhayat
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 50
Extracellular vesicles in pancreatic cancer progression and therapies
Chao‐Hui Chang, Siim Pauklin
Cell Death and Disease (2021) Vol. 12, Iss. 11
Open Access | Times Cited: 47
Exosome‐derived miR‐210 involved in resistance to osimertinib and epithelial–mesenchymal transition in EGFR mutant non‐small cell lung cancer cells
Kakeru Hisakane, Masahiro Seike, Teppei Sugano, et al.
Thoracic Cancer (2021) Vol. 12, Iss. 11, pp. 1690-1698
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top